Marietta Investment Partners’s GSK GSK Stock Holding History

Marietta Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,542	Closed	-$791K	–	168
2022 Q2	$791K	Buy	14,542 +2,800	+24%	+$155K	0.24%	87
2022 Q1	$639K	Hold	11,742	–	–	0.15%	113
2021 Q4	$647K	Hold	11,742	–	–	0.14%	115
2021 Q3	$561K	Hold	11,742	–	–	0.13%	119
2021 Q2	$584K	Buy	11,742 +576	+5%	+$27.7K	0.13%	113
2021 Q1	$498K	Hold	11,166	–	–	0.12%	121
2020 Q4	$514K	Sell	11,166 -1,120	-9%	-$51.4K	0.13%	105
2020 Q3	$578K	Hold	12,286	–	–	0.17%	90
2020 Q2	$626K	Hold	12,286	–	–	0.21%	80
2020 Q1	$582K	Buy	12,286 +1,006	+9%	+$53.7K	0.25%	74
2019 Q4	$663K	Buy	11,280 +2,400	+27%	+$134K	0.22%	83
2019 Q3	$474K	Hold	8,880	–	–	0.16%	96
2019 Q2	$444K	Buy	8,880 +3,120	+54%	+$157K	0.15%	102
2019 Q1	$301K	Hold	5,760	–	–	0.09%	119
2018 Q4	$275K	Buy	+5,760	New	+$284K	0.11%	108
2016 Q4	–	Sell	-6,000	Closed	-$323K	–	143
2016 Q3	$323K	Buy	+6,000	New	+$329K	0.11%	118

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Marietta Investment Partners's GSK Position: Q3 2022 in Review

Marietta Investment Partners sold out of GSK (GSK) in Q3 2022, closing a stake of 14,542 shares — an estimated $791K sold.

Marietta Investment Partners first reported a position in GSK in Q3 2016 and held it in 16 quarters. The position peaked at $791K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Marietta Investment Partners reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Marietta Investment Partners sold 14,542 GSK shares in Q3 2022, an estimated $791K.
Marietta Investment Partners first reported a position in GSK in Q3 2016 and held it in 16 quarters.
Marietta Investment Partners's GSK position peaked at $791K in Q2 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Marietta Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.